<DOC>
	<DOCNO>NCT00989794</DOCNO>
	<brief_summary>This single arm , open label multi-center study determine safety performance treatment cartilage lesion locate femoral condyle GelrinC . Patients meet inclusion/exclusion criterion screen enrol study , receive treatment implantation cartilage lesion . Treatment consist GelrinC implantation symptomatic lesion femur rat ICRS III , IVA le 6 mm bone loss subchondral plate . The patient undergo rehabilitation program follow period .</brief_summary>
	<brief_title>Study Evaluate Safety Performance Treatment Articular Cartilage Lesions Located Femoral Condyle With gelrinC</brief_title>
	<detailed_description />
	<criteria>1 . Males females 18 65 year age . 2 . Not two treatable symptomatic lesion NOT posterior ; patient must present pain index knee moderate severe level ( VAS score â‰¥5 ) 3 . If Female : Actively practice contraception method , Practicing abstinence , Surgically sterilize , Postmenopausal 4 . Understands voluntarily sign date inform consent document . 5 . Grade 3 4 acute ( traumatic ) chronic ( degenerative ) lesion 6 . Willingness follow standardize rehabilitation procedure . 7 . Willingness ability comply requirement protocol , include return evaluation ( clinical imaging ) periodic interval posttreatment . 8 . Study knee intact ligament 9 . Ipsilateral knee compartment intact meniscus ( require partial meniscectomy result stable meniscus ) 10 . Contralateral knee asymptomatic , stable fully functional . 11 . MRI obtain preoperatively within 3 month Surgery Intraoperative Arthroscopic Confirmation : 12. one two symptomatic lesion femur rat ICRS III , IVA le 6 mm bone loss subchondral plate 13 . Individual defect size 1 cm2 6 cm2 arthroscopic debridement 1 . More two symptomatic lesion 2 . Untreatable Posterior lesion 3 . Lesion great 6cm2 4 . ICRS Grade large grade II surface directly oppose defect 5 . Osteoarthritis avascular necrosis ( clinical and/or radiographic diagnosis ) 6 . History autoimmune disease inflammatory arthropathy , rheumatoid arthritis , systemic lupus , active gout , septic reactive arthritis include history positive ANA blood test . 7 . History chronic debilitate systemic disease unstable cardiac pulmonary disorder . 8 . History current prior malignancy within last 5 year . 9 . Patients treat affected knee microfracture last 12m month prior tendon repair , meniscus repair , ligament repair realignment surgery last 6 month . 10 . Patient prior total subtotal meniscectomy . 11 . Body Mass Index ( BMI ) &gt; 32 Kg/m2 12 . ` Patients know HIV , Hepatitis A , B , C infection immunodeficient state . 13 . Patients require immunosuppressive medication . 14 . Clinically significant organic disease include clinically significant cardiovascular , pulmonary , neurologic , hepatic renal disease medical condition , serious concurrent illness extenuate circumstance , opinion investigator , make subject poor candidate participation study . 15 . Patients receive investigational product within 6 month prior study enrollment . 17.Taking specific OA drug chondroitin sulfate , diacerein , nglucosamine , piascledine , capsaicin within 2 week screen 18.Is receive prescription pain medication NSAIDs acetaminophen condition unrelated index knee condition , chronic use anticoagulant , take corticosteroid 19.Uncontrolled diabetes 20.Any concomitant painful disable disease spine , hip low limb would interfere evaluation afflict knee 21.Any clinically significant symptomatic vascular neurologic disorder low extremity 22.Any evidence follow disease target joint : septic arthritis , inflammatory joint disease , gout , recurrent episode pseudogout , Paget 's disease bone , ochronosis , acromegaly , hemochromatosis , Wilson 's disease , primary osteochondromatosis , heritable disorder , collagen gene mutation 23.Current diagnosis osteomyelitis 24.Liver enzyme ( SGOT , SGPT , Alkaline Phosphatase ) two time upper limit normal result clinically important accord Investigator 25.CRP &gt; 10 mg/l 26.Clinically significant abnormal find screen laboratory parameter . 27.Clinically relevant compartment malalignment ( &gt; 5 degree ) measure mechanical axis verify clinical assessment radiographic imaging require 28.Patients history bleeding disorder , patient receive antiplatelet therapy anticoagulant medication use within 10 day prior begin study , patient antiplatelet anticoagulant medication use anticipate course study . However , patient lowdose aspirin may include study aspirin therapy interrupt least 10 day treatment resume least 2 week treatment .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>November 2016</verification_date>
	<keyword>cartilage</keyword>
	<keyword>implantation</keyword>
	<keyword>chondrocyte</keyword>
	<keyword>condyle</keyword>
</DOC>